公司简介（英文）(Company Introduction)
Unisons Biotechnology Co., Ltd. is specialized in the development, manufacturing and distribution of probiotics and their derivatives. Unisons Ningbo production base covers an area of 52,394 square meters, with nearly 70,000 square meters of premises including over 10,000 square meters of Class 100,000 cleanrooms. It is equipped with fully automated production lines with a planned total annual output of 100,000 tons; for the first phase, an annual production capacity of 400 tons of bacterial powders will be enabled in early 2023.
Leveraging decades of basic research achievements from Japan and the pharmaceutical R&D team from the USA, Unisons has forged professional capabilities for probiotic formula development and screening. Aiming at the customized application fields of probiotics such as intestinal health, women's health, oral health, and emotion regulation, we provide a full-process service system from market demand investigation, and formula design optimization to product manufacturing and packaging, and marketing strategy support. Our business covers industries including food, pharmaceuticals, dairy products, and (e-commerce) sales platforms, etc.
|
